Beta Bionics, Inc. (BBNX) vs Tandem Diabetes Care, Inc. (TNDM)
Beta Bionics, Inc. and Tandem Diabetes Care, Inc. are both Medical Devices companies. Beta Bionics, Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 3.96%. Tandem Diabetes Care, Inc. has the higher net margin (−6.08% vs −61.3%) and the higher return on invested capital (−10.3% vs −68.5%). Across the 17 metrics below, Tandem Diabetes Care, Inc. leads on 10 and Beta Bionics, Inc. on 7.
Valuation
Profitability
| Metric | BBNX | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.31% | 56.01% | 56.01% |
| Operating margin | (69.75%) | (4.40%) | (15.03%) |
| Net margin | (61.32%) | (6.08%) | (20.40%) |
| Free cash flow margin | (284.13%) | (2.56%) | (7.24%) |
| Return on equity | (26.16%) | (48.03%) | (15.32%) |
| Return on assets | (23.45%) | (6.24%) | (19.72%) |
| Return on invested capital | (68.47%) | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack